MA22.03 SCLC Circulating Tumour Cell Derived Explants: The Clinical Characteristics of Patients Whose Samples Generate CDX

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.503
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Clinical Utility of Circulating Tumour Cells in Patients With Small Cell Lung Cancer

Translational Lung Cancer Research
Oncology
2017English

Circulating Tumour Cell-Derived Plastin3 Is a Novel Marker for Predicting Long-Term Prognosis in Patients With Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

P1.12-15 Distinctive Clinical Characteristics of SCLC in Never-Smokers

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Method Validation of Circulating Tumour Cell Enumeration at Low Cell Counts

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

Circulating Tumour Cells in Oral Squamous Cell Carcinoma

Dental Poster Journal
2020English

Characterisation of Tumour-Derived Microvesicles in Cancer Patients’ Blood and Correlation With Clinical Outcome

Journal of Extracellular Vesicles
Cell BiologyHistology
2017English

SEOM Clinical Guidelines for the Treatment of Small-Cell Lung Cancer (SCLC) (2019)

Clinical and Translational Oncology
MedicineCancer ResearchOncology
2020English

Single-Cell Profiling of Circulating Tumour Cells: A Great Leap Forward

Journal of Chemical Biology
BiochemistryCell BiologyBiophysics
2012English

Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress

Frontiers in Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy